Key points from article :
Gene therapy could disable genes that sustain levels of lipids in the bloodstream.
Number of credible targets including PCSK9, ANGPTL3, ANGPTL4, and ASGR1.
Reducing lipid levels in the bloodstream slows the development of CVD.
Treatments will initially have a low effectiveness in terms of proportion of cells transfected.